Novartis Earnings

• 

  Novartis India Sheds Over 6% Even After Net Profit Rises 43% In March Quarter

  Novartis India Share Price Today: On Friday, Novartis India opened on the BSE at Rs 881, swinging to an intra day high of Rs 883.35 and an intra day low of Rs 797.35, so far

• 

  Novartis Q2 Net Profit At Rs 22 Crore

  Pharma company Novartis India today reported a standalone net profit of Rs 22.21 crore for the quarter ended September 30, 2016.

• 

  Novartis India Q1 Net Profit At Rs 19 Crore

  Drug firm Novartis India reported a standalone net profit of Rs 19.07 crore for the first quarter ended June 30, 2016.

• 

  Novartis Slumps On Q4 Result Disappointment

  Shares of drug firm Novartis India on Friday slumped 13 per cent on disappointment over the company's earnings for the quarter ended March 2016.

• 

  Novartis Posts Rs 22 Crore Profit In Q4

  Drug firm Novartis India on Thursday reported a standalone net profit of Rs 21.53 crore for the quarter ended March 31, 2016.

• 

  Novartis India Posts Rs 60-Crore Net Profit in Q3

  Novartis India on Thursday reported a net profit of Rs 59.81 crore for the third quarter ended December 31. The company had posted a net loss of Rs 1.18 crore in the same period last fiscal, Novartis India said in a BSE filing.

• 

  Novartis India Q2 Net Rises to Rs 104 Crore

  The company's board in January had approved a slump sale of OTC business to GSK Consumer Private Limited.

• 

  Novartis Profit Hit by $390 Million Settlement in US Kickbacks Case

  Novartis has agreed in principle to pay $390 million to settle US allegations that it used kickbacks to speciality pharmacies to push sales of some drugs, the Swiss company said on Tuesday, hitting third-quarter earnings.

• Novartis India Q1 Net Profit Falls 6% to Rs 13 Crore

  The company had posted a net profit of Rs 14.31 crore in the corresponding period of the previous fiscal, Novartis India said in a filing to the BSE.

• Novartis India Posts Two-Fold Jump in Q4 Profit

  Pharmaceuticals firm Novartis India on Wednesday reported a jump of over two-fold in standalone net at Rs 51.94 crore for the quarter ended March, 2015.

• 

  GlaxoSmithKline Pharma Q3 Net Declines 61% to Rs 45 Crore

  The company, which today reported a 61.24 per cent drop in its net profit at Rs 45.30 crore for the October-December period, said its board approved the transactions on an asset sale basis with Novartis Healthcare Pvt Ltd.

• Novartis Posts Loss of Rs 1.18 Crore in Q3

  Drugmaker Novartis India Ltd on Wednesday reported a net loss of Rs 1.18 crore for the third quarter that ended on December 31, 2014.

• Novartis Posts 69 Per Cent Decline in Q2 Profit

  Drug firm Novartis India on Friday registered a 69.14 per cent decline in net profit at Rs 14.04 crore for the quarter ended September 2014.

• Novartis India Q1 Net Up 3 Per Cent at Rs 14.31 Crore

  Drug firm Novartis India on Friday reported a 3.17 per cent rise in standalone net profit at Rs 14.31 crore for the quarter ended June 30, 2014.

• Novartis India Q4 Net Dips 2 Per Cent to Rs 23.88 Crore

  Drug firm Novartis India on Thursday reported a 2.17 per cent dip in net profit at Rs 23.88 crore for the quarter ended March, due to adverse impacts of the new drug pricing policy.